How much does Dasatinib cost per month?

Dasatinib (Dasatinib) is only available by prescription, and treatment should be initiated and supervised by a physician experienced in diagnosing and treating leukemia. Dasatinib is available for oral administration in tablets (20, 50, 70, 80, 100 and 140 mg) and powder (10 mg/mL). It is usually taken once a day, morning and evening. The dosages of dasatinib tablets and suspension are different. The starting dose depends on the condition being treated and, in children, their weight. The dose is then gradually increased until the disease is controlled well enough.

For children with acute lymphoblastic leukemia (ALL) who are being treated with other cancer drugs, use a fixed dose of dasatinib throughout treatment. Your doctor may reduce your dose or interrupt your treatment if your blood counts are too low or certain side effects occur. Treatment is stopped if the medication no longer controls the condition or if the patient cannot take the medication due to side effects.

The original drug of dasatinib has been launched in China and is included in the medical insurance. Currently, reimbursement is only available to eligible patients. Common specifications The price of each box of 50mg*60 tablets may be around RMB 10,000. The original drug overseas is even more expensive. Taking the dose of chronic phase CML in adults as an example, the recommended starting dose is 100mg orally taken once a day. A rough calculation may cost the patient 10,000 yuan a month.

Dasatinib generics are also sold overseas. The ingredients of the drug are basically the same as those sold domestically and abroad, but the price is cheap, such as the specifications produced by Indian pharmaceutical factories. The price of each box of 50mg*60 tablets may be several hundred RMB (the price may fluctuate due to the exchange rate). A rough calculation may mean that a patient may need 1,000 RMB per month. For information on Dasatinib’s overseas drug prices and related information, please consult a medical consultant.